| Follow us on Twitter |
The share transfer means that Mochida Siemens Medical Systems Co., Ltd. will become a fully consolidated subsidiary of Siemens and an equity-consolidated affiliate of Mochida Pharmaceutical Co., Ltd.
The joint venture’s current President, and Representative Director, Shuichi Ishii, will retain his position and take on additional responsibilities as the company’s Chief Operating Officer (COO). Holger Klotz, currently the Managing Director and CEO of Mobisphere Ltd., a Siemens and NEC Joint Venture, will join the management team as CEO, Chairman and Representative Director.
Since its formation in 2004, the joint venture Mochida Siemens Medical Systems has steadily expanded its business in the diagnostic ultrasound market in Japan, especially in the obstetrics and gynecology market where it holds a significant market share. With the new International management and a comprehensive product and applications portfolio, Siemens-Mochida plans to expand its position in the cardiovascular and internal medicine markets, addressing the health issues in Japan across the entire spectrum of ultrasound solutions.-Siemens
Posted October 2nd, 2007 by harminka
